Who Owns Mesoblast Stock?
NASDAQ: MESOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 3.38%
- Held by insiders
- 57.34%
- Institutional holders
- 96
- Institutions 3.4%
- Insiders 57.3%
- Public and other 39.3%
Who owns Mesoblast stock?
Institutional investors own about 3.4% of Mesoblast's shares, spread across 96 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 57.34% of MESO.
The largest institutional holders are Morgan Stanley (0.55%), Blackrock Inc. (0.51%) and Susquehanna International Group, LLP (0.35%). Together, the top 10 institutions control 2.4% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their MESO positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of MESO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Morgan Stanley | 718.61K | 0.55% | +39.7% |
| Blackrock Inc. | 664.28K | 0.51% | +5.3% |
| Susquehanna International Group, LLP | 457.74K | 0.35% | +18.4% |
| Goldman Sachs Group Inc | 395.61K | 0.30% | -0.4% |
| BNP Paribas Asset Management Holding S.A. | 259.70K | 0.20% | +100.0% |
| UBS Group AG | 197.18K | 0.15% | -1.4% |
| Arax Advisory Partners | 175.32K | 0.13% | +4.3% |
| Group One Trading, LLC | 132.24K | 0.10% | +200.3% |
| Bank of America Corporation | 100.00K | 0.08% | 0.0% |
| Penbrook Management LLC | 87.08K | 0.07% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of MESO
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Biotechnology ETF | 573.61K | 0.44% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 34.22K | 0.03% |
| Trust for Professional Managers-ActivePassive International Equity ETF | 8.84K | 0.01% |
| Invesco Exch-Trd Fd. TRT II-Invesco NASDAQ Future Gen 200 ETF | 7.16K | 0.01% |
| Steward Funds Inc-Steward Values Enhanced International Fund | 6.51K | 0.01% |
| Invesco Exchange-Traded Fund Trust II-Invesco Nasdaq Biotechnology ETF | 3.27K | 0.00% |
| ProShares Trust-ProShares Ultra Nasdaq Biotechnology | 2.09K | 0.00% |
Frequently asked questions
Who is the largest shareholder of Mesoblast?
Morgan Stanley is the largest institutional shareholder of MESO, owning 0.55% of shares outstanding (718.61K shares) as of its latest 13F filing.
What percentage of Mesoblast is owned by institutions?
Institutions own about 3.4% of MESO shares and 7.9% of the public float.
How much of Mesoblast do insiders own?
Insiders, such as officers and directors, own about 57.34% of MESO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.